IndiaInfoline » Markets » APLLTD

Alembic Pharmaceuticals Ltd - Share Price

APLLTD

Open

540.00

Prev. Close

545.70

Turnover (lac.)

65

Day's High

548.00

Day's Low

532.00

52 Week's High

639.90

52 Week's Low

435.15

Book Value

152

Face Value

2

Mkt Cap (Cr.)

10,093

P/E

15.47

EPS

34.61

Divi. Yield

1.03

Financials

Switch to
Consolidated
Standalone

Loading ...

News & Updates

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd394.6543.2294,677.76763.370.703,020.4995.21
Divis Laboratories Ltd1,683.7033.5044,682.34267.350.951,139.92262.68
Dr Reddys Laboratories Ltd2,651.9029.4144,010.35548.100.752,497.60766.66
Cipla Ltd440.9016.2135,535.93694.000.683,126.21195.79
Lupin Ltd716.4019.1732,382.41445.930.702,878.91378.16

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

sentifi.com

Indiainfoline Sentifi Top 10 Most Talked About Stocks

Summary & Reports

No Company Summary found

Registered Office

Alembic Road,,Vadodara, Gujarat,390003

Tell. : +91-0265-2280550
Website : http://www.alembicpharmaceuticals.com
Email : apl.investors@alembic.co.in

Registrar Office

B-102&103 Shangrila, Akota, Vadodara - 390 020 INDIA

Tell. : +91-265-2356573/23567
Website : www.linkintime.co.in
Email : vadodara@linktime.co.in

Latest Release by alembic-pharmaceuticals-ltd

View

- <

Reco. Price

Oct 04,2019 11:27 AM

Target Price

Target Returns:

0.00%

Result Express

Alembic Pharmaceuticals Ltd's Q3FY19 consolidated net profit rises 30.49% yoy to Rs170.75cr : In-line with Estimates

Oct 14, 2019 09:39 PM

The company’s consolidated revenue stood at Rs1,018.15cr, up 21.21% yoy but down 9.66% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    29 Jul 2019

    Annc. Date

    18 Jul 2019

    ALEMBIC PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Compa... More

  • Purpose

    AGM

    Exp. Date

    29 Jul 2019

    Annc. Date

    10 Jun 2019

    AGM 29/07/2019Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements... More

  • Purpose

    Dividend

    Annc. Date

    08 May 2019

    Effective. Date

    18 Jul 2019

    Divi. Type

    Final

    Divi.(%)

    275

    Divi. Amt.

    5.5

    Alembic Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeti... More